Cargando…
miR‐134 inhibits non‐small cell lung cancer growth by targeting the epidermal growth factor receptor
The epidermal growth factor receptor (EGFR) is frequently activated in a wide range of solid tumours and represents an important therapeutic target. MicroRNAs (miRNAs) have recently been recognized as a rational and potential modality for anti‐EGFR therapies. However, more EGFR‐targeting miRNAs need...
Autores principales: | Qin, Qin, Wei, Furong, Zhang, Jianbo, Wang, Xingwu, Li, Baosheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891324/ https://www.ncbi.nlm.nih.gov/pubmed/27241841 http://dx.doi.org/10.1111/jcmm.12889 |
Ejemplares similares
-
Multiple functions of hypoxia-regulated miR-210 in cancer
por: Qin, Qin, et al.
Publicado: (2014) -
miR-134-5p inhibits osteoclastogenesis through a novel miR-134-5p/Itgb1/MAPK pathway
por: Huang, Meng, et al.
Publicado: (2022) -
Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor
por: Li, Xiaoling, et al.
Publicado: (2020) -
miR-202 Inhibits Cell Proliferation, Migration, and Invasion by Targeting Epidermal Growth Factor Receptor in Human Bladder Cancer
por: Zhang, Liqing, et al.
Publicado: (2018) -
Epidermal growth factor receptor-regulated miR-125a-5p – a metastatic inhibitor of lung cancer
por: Wang, Guofu, et al.
Publicado: (2009)